Daratumumab Plus VRd for Multiple Myeloma
124
0
2024-3-21 17:24
Drug-Eluting Scaffold for Infrapopliteal Disease
2023 Notable Articles | New England Journal of Medicine
Welcome Video from the Editors of NEJM Evidence
Medical Mystery Solved – The Road Less Traveled
New Patient-Centered Options for Cancer Treatment
多发性骨骼瘤
The Plight of Primary Care, Part 2
Understanding Heparin-Induced Thrombocytopenia (HIT)：Causes, pathophysiology, and Treatment
0 bullet chats
Please Sign In first
LikesSend-PenFavorites
Scan by WeChatUnauthorized reproduction is prohibited
New multiple myeloma treatments are needed to attain long-term disease control. Adding the monoclonal antibody daratumumab to standard therapy has shown potential for improving outcomes.
Comments 0
Please to post a comment~
Loading...
Related Suggestion